Table of Content

1 Mucopolysaccharidosis II Market Overview
1.1 Product Overview and Scope of Mucopolysaccharidosis II
1.2 Mucopolysaccharidosis II Segment by Type
1.2.1 Global Mucopolysaccharidosis II Market Value Comparison by Type (2024-2034)
1.2.2 JR-141
1.2.3 EGT-301
1.2.4 DUOC-01
1.2.5 AGT-182
1.2.6 JR-032
1.2.7 Others
1.3 Mucopolysaccharidosis II Segment by Application
1.3.1 Global Mucopolysaccharidosis II Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Global Mucopolysaccharidosis II Market Size Estimates and Forecasts
1.4.1 Global Mucopolysaccharidosis II Revenue 2018-2034
1.4.2 Global Mucopolysaccharidosis II Sales 2018-2034
1.4.3 Global Mucopolysaccharidosis II Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Mucopolysaccharidosis II Market Competition by Manufacturers
2.1 Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2018-2024)
2.2 Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Mucopolysaccharidosis II Average Price by Manufacturers (2018-2024)
2.4 Global Mucopolysaccharidosis II Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Mucopolysaccharidosis II, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mucopolysaccharidosis II, Product Type & Application
2.7 Mucopolysaccharidosis II Market Competitive Situation and Trends
2.7.1 Mucopolysaccharidosis II Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mucopolysaccharidosis II Players Market Share by Revenue
2.7.3 Global Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mucopolysaccharidosis II Retrospective Market Scenario by Region
3.1 Global Mucopolysaccharidosis II Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Mucopolysaccharidosis II Global Mucopolysaccharidosis II Sales by Region: 2018-2034
3.2.1 Global Mucopolysaccharidosis II Sales by Region: 2018-2024
3.2.2 Global Mucopolysaccharidosis II Sales by Region: 2024-2034
3.3 Global Mucopolysaccharidosis II Global Mucopolysaccharidosis II Revenue by Region: 2018-2034
3.3.1 Global Mucopolysaccharidosis II Revenue by Region: 2018-2024
3.3.2 Global Mucopolysaccharidosis II Revenue by Region: 2024-2034
3.4 North America Mucopolysaccharidosis II Market Facts & Figures by Country
3.4.1 North America Mucopolysaccharidosis II Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Mucopolysaccharidosis II Sales by Country (2018-2034)
3.4.3 North America Mucopolysaccharidosis II Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mucopolysaccharidosis II Market Facts & Figures by Country
3.5.1 Europe Mucopolysaccharidosis II Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Mucopolysaccharidosis II Sales by Country (2018-2034)
3.5.3 Europe Mucopolysaccharidosis II Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mucopolysaccharidosis II Market Facts & Figures by Country
3.6.1 Asia Pacific Mucopolysaccharidosis II Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Mucopolysaccharidosis II Sales by Country (2018-2034)
3.6.3 Asia Pacific Mucopolysaccharidosis II Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mucopolysaccharidosis II Market Facts & Figures by Country
3.7.1 Latin America Mucopolysaccharidosis II Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Mucopolysaccharidosis II Sales by Country (2018-2034)
3.7.3 Latin America Mucopolysaccharidosis II Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mucopolysaccharidosis II Market Facts & Figures by Country
3.8.1 Middle East and Africa Mucopolysaccharidosis II Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Mucopolysaccharidosis II Sales by Country (2018-2034)
3.8.3 Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mucopolysaccharidosis II Sales by Type (2018-2034)
4.1.1 Global Mucopolysaccharidosis II Sales by Type (2018-2024)
4.1.2 Global Mucopolysaccharidosis II Sales by Type (2024-2034)
4.1.3 Global Mucopolysaccharidosis II Sales Market Share by Type (2018-2034)
4.2 Global Mucopolysaccharidosis II Revenue by Type (2018-2034)
4.2.1 Global Mucopolysaccharidosis II Revenue by Type (2018-2024)
4.2.2 Global Mucopolysaccharidosis II Revenue by Type (2024-2034)
4.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Type (2018-2034)
4.3 Global Mucopolysaccharidosis II Price by Type (2018-2034)
5 Segment by Application
5.1 Global Mucopolysaccharidosis II Sales by Application (2018-2034)
5.1.1 Global Mucopolysaccharidosis II Sales by Application (2018-2024)
5.1.2 Global Mucopolysaccharidosis II Sales by Application (2024-2034)
5.1.3 Global Mucopolysaccharidosis II Sales Market Share by Application (2018-2034)
5.2 Global Mucopolysaccharidosis II Revenue by Application (2018-2034)
5.2.1 Global Mucopolysaccharidosis II Revenue by Application (2018-2024)
5.2.2 Global Mucopolysaccharidosis II Revenue by Application (2024-2034)
5.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Application (2018-2034)
5.3 Global Mucopolysaccharidosis II Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Alexion Pharmaceuticals, Inc.
6.1.1 Alexion Pharmaceuticals, Inc. Corporation Information
6.1.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
6.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio
6.1.5 Alexion Pharmaceuticals, Inc. Recent Developments/Updates
6.2 AngioChem Inc.
6.2.1 AngioChem Inc. Corporation Information
6.2.2 AngioChem Inc. Description and Business Overview
6.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AngioChem Inc. Mucopolysaccharidosis II Product Portfolio
6.2.5 AngioChem Inc. Recent Developments/Updates
6.3 ArmaGen Inc.
6.3.1 ArmaGen Inc. Corporation Information
6.3.2 ArmaGen Inc. Description and Business Overview
6.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.3.4 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio
6.3.5 ArmaGen Inc. Recent Developments/Updates
6.4 Bioasis Technologies Inc.
6.4.1 Bioasis Technologies Inc. Corporation Information
6.4.2 Bioasis Technologies Inc. Description and Business Overview
6.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio
6.4.5 Bioasis Technologies Inc. Recent Developments/Updates
6.5 Green Cross Corporation
6.5.1 Green Cross Corporation Corporation Information
6.5.2 Green Cross Corporation Description and Business Overview
6.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Green Cross Corporation Mucopolysaccharidosis II Product Portfolio
6.5.5 Green Cross Corporation Recent Developments/Updates
6.6 Inventiva
6.6.1 Inventiva Corporation Information
6.6.2 Inventiva Description and Business Overview
6.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Inventiva Mucopolysaccharidosis II Product Portfolio
6.6.5 Inventiva Recent Developments/Updates
6.7 JCR Pharmaceuticals Co., Ltd.
6.6.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
6.6.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
6.6.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.4.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio
6.7.5 JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.8 Laboratorios Del Dr. Esteve S.A.
6.8.1 Laboratorios Del Dr. Esteve S.A. Corporation Information
6.8.2 Laboratorios Del Dr. Esteve S.A. Description and Business Overview
6.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio
6.8.5 Laboratorios Del Dr. Esteve S.A. Recent Developments/Updates
6.9 RegenxBio Inc.
6.9.1 RegenxBio Inc. Corporation Information
6.9.2 RegenxBio Inc. Description and Business Overview
6.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.9.4 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio
6.9.5 RegenxBio Inc. Recent Developments/Updates
6.10 Sangamo BioSciences, Inc.
6.10.1 Sangamo BioSciences, Inc. Corporation Information
6.10.2 Sangamo BioSciences, Inc. Description and Business Overview
6.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio
6.10.5 Sangamo BioSciences, Inc. Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Mucopolysaccharidosis II Description and Business Overview
6.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Takeda Mucopolysaccharidosis II Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mucopolysaccharidosis II Industry Chain Analysis
7.2 Mucopolysaccharidosis II Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mucopolysaccharidosis II Production Mode & Process
7.4 Mucopolysaccharidosis II Sales and Marketing
7.4.1 Mucopolysaccharidosis II Sales Channels
7.4.2 Mucopolysaccharidosis II Distributors
7.5 Mucopolysaccharidosis II Customers
8 Mucopolysaccharidosis II Market Dynamics
8.1 Mucopolysaccharidosis II Industry Trends
8.2 Mucopolysaccharidosis II Market Drivers
8.3 Mucopolysaccharidosis II Market Challenges
8.4 Mucopolysaccharidosis II Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Mucopolysaccharidosis II Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Mucopolysaccharidosis II Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Mucopolysaccharidosis II Market Competitive Situation by Manufacturers in 2022
Table 4. Global Mucopolysaccharidosis II Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Mucopolysaccharidosis II Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Mucopolysaccharidosis II Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Mucopolysaccharidosis II Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Mucopolysaccharidosis II, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Mucopolysaccharidosis II, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mucopolysaccharidosis II, Product Type & Application
Table 12. Global Key Manufacturers of Mucopolysaccharidosis II, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mucopolysaccharidosis II Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Mucopolysaccharidosis II Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Mucopolysaccharidosis II Sales Market Share by Region (2018-2024)
Table 19. Global Mucopolysaccharidosis II Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Mucopolysaccharidosis II Sales Market Share by Region (2024-2034)
Table 21. Global Mucopolysaccharidosis II Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Region (2018-2024)
Table 23. Global Mucopolysaccharidosis II Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Mucopolysaccharidosis II Revenue Market Share by Region (2024-2034)
Table 25. North America Mucopolysaccharidosis II Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Mucopolysaccharidosis II Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Mucopolysaccharidosis II Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Mucopolysaccharidosis II Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Mucopolysaccharidosis II Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Mucopolysaccharidosis II Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Mucopolysaccharidosis II Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Mucopolysaccharidosis II Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Mucopolysaccharidosis II Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Mucopolysaccharidosis II Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Mucopolysaccharidosis II Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Mucopolysaccharidosis II Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Mucopolysaccharidosis II Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Mucopolysaccharidosis II Sales (K Pcs) by Type (2018-2024)
Table 51. Global Mucopolysaccharidosis II Sales (K Pcs) by Type (2024-2034)
Table 52. Global Mucopolysaccharidosis II Sales Market Share by Type (2018-2024)
Table 53. Global Mucopolysaccharidosis II Sales Market Share by Type (2024-2034)
Table 54. Global Mucopolysaccharidosis II Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Mucopolysaccharidosis II Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Mucopolysaccharidosis II Revenue Market Share by Type (2018-2024)
Table 57. Global Mucopolysaccharidosis II Revenue Market Share by Type (2024-2034)
Table 58. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2018-2024)
Table 61. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2024-2034)
Table 62. Global Mucopolysaccharidosis II Sales Market Share by Application (2018-2024)
Table 63. Global Mucopolysaccharidosis II Sales Market Share by Application (2024-2034)
Table 64. Global Mucopolysaccharidosis II Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Mucopolysaccharidosis II Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Mucopolysaccharidosis II Revenue Market Share by Application (2018-2024)
Table 67. Global Mucopolysaccharidosis II Revenue Market Share by Application (2024-2034)
Table 68. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2024-2034)
Table 70. Alexion Pharmaceuticals, Inc. Corporation Information
Table 71. Alexion Pharmaceuticals, Inc. Description and Business Overview
Table 72. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product
Table 74. Alexion Pharmaceuticals, Inc. Recent Developments/Updates
Table 75. AngioChem Inc. Corporation Information
Table 76. AngioChem Inc. Description and Business Overview
Table 77. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. AngioChem Inc. Mucopolysaccharidosis II Product
Table 79. AngioChem Inc. Recent Developments/Updates
Table 80. ArmaGen Inc. Corporation Information
Table 81. ArmaGen Inc. Description and Business Overview
Table 82. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. ArmaGen Inc. Mucopolysaccharidosis II Product
Table 84. ArmaGen Inc. Recent Developments/Updates
Table 85. Bioasis Technologies Inc. Corporation Information
Table 86. Bioasis Technologies Inc. Description and Business Overview
Table 87. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Bioasis Technologies Inc. Mucopolysaccharidosis II Product
Table 89. Bioasis Technologies Inc. Recent Developments/Updates
Table 90. Green Cross Corporation Corporation Information
Table 91. Green Cross Corporation Description and Business Overview
Table 92. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Green Cross Corporation Mucopolysaccharidosis II Product
Table 94. Green Cross Corporation Recent Developments/Updates
Table 95. Inventiva Corporation Information
Table 96. Inventiva Description and Business Overview
Table 97. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Inventiva Mucopolysaccharidosis II Product
Table 99. Inventiva Recent Developments/Updates
Table 100. JCR Pharmaceuticals Co., Ltd. Corporation Information
Table 101. JCR Pharmaceuticals Co., Ltd. Description and Business Overview
Table 102. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product
Table 104. JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 105. Laboratorios Del Dr. Esteve S.A. Corporation Information
Table 106. Laboratorios Del Dr. Esteve S.A. Description and Business Overview
Table 107. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product
Table 109. Laboratorios Del Dr. Esteve S.A. Recent Developments/Updates
Table 110. RegenxBio Inc. Corporation Information
Table 111. RegenxBio Inc. Description and Business Overview
Table 112. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. RegenxBio Inc. Mucopolysaccharidosis II Product
Table 114. RegenxBio Inc. Recent Developments/Updates
Table 115. Sangamo BioSciences, Inc. Corporation Information
Table 116. Sangamo BioSciences, Inc. Description and Business Overview
Table 117. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product
Table 119. Sangamo BioSciences, Inc. Recent Developments/Updates
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Takeda Mucopolysaccharidosis II Product
Table 124. Takeda Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Mucopolysaccharidosis II Distributors List
Table 128. Mucopolysaccharidosis II Customers List
Table 129. Mucopolysaccharidosis II Market Trends
Table 130. Mucopolysaccharidosis II Market Drivers
Table 131. Mucopolysaccharidosis II Market Challenges
Table 132. Mucopolysaccharidosis II Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mucopolysaccharidosis II
Figure 2. Global Mucopolysaccharidosis II Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Mucopolysaccharidosis II Market Share by Type in 2022 & 2034
Figure 4. JR-141 Product Picture
Figure 5. EGT-301 Product Picture
Figure 6. DUOC-01 Product Picture
Figure 7. AGT-182 Product Picture
Figure 8. JR-032 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Mucopolysaccharidosis II Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Mucopolysaccharidosis II Market Share by Application in 2022 & 2034
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Research Center
Figure 15. Others
Figure 16. Global Mucopolysaccharidosis II Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Mucopolysaccharidosis II Market Size (2018-2034) & (US$ Million)
Figure 18. Global Mucopolysaccharidosis II Sales (2018-2034) & (K Pcs)
Figure 19. Global Mucopolysaccharidosis II Average Price (USD/Pcs) & (2018-2034)
Figure 20. Mucopolysaccharidosis II Report Years Considered
Figure 21. Mucopolysaccharidosis II Sales Share by Manufacturers in 2022
Figure 22. Global Mucopolysaccharidosis II Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Mucopolysaccharidosis II Players: Market Share by Revenue in 2022
Figure 24. Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Mucopolysaccharidosis II Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 26. North America Mucopolysaccharidosis II Sales Market Share by Country (2018-2034)
Figure 27. North America Mucopolysaccharidosis II Revenue Market Share by Country (2018-2034)
Figure 28. U.S. Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Canada Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Europe Mucopolysaccharidosis II Sales Market Share by Country (2018-2034)
Figure 31. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2018-2034)
Figure 32. Germany Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. France Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. U.K. Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Italy Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Russia Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Mucopolysaccharidosis II Sales Market Share by Region (2018-2034)
Figure 38. Asia Pacific Mucopolysaccharidosis II Revenue Market Share by Region (2018-2034)
Figure 39. China Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Japan Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. South Korea Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. India Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Australia Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Taiwan Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Indonesia Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Thailand Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Malaysia Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Philippines Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Latin America Mucopolysaccharidosis II Sales Market Share by Country (2018-2034)
Figure 50. Latin America Mucopolysaccharidosis II Revenue Market Share by Country (2018-2034)
Figure 51. Mexico Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Argentina Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2018-2034)
Figure 55. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2018-2034)
Figure 56. Turkey Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Saudi Arabia Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. U.A.E Mucopolysaccharidosis II Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. Global Sales Market Share of Mucopolysaccharidosis II by Type (2018-2034)
Figure 60. Global Revenue Market Share of Mucopolysaccharidosis II by Type (2018-2034)
Figure 61. Global Mucopolysaccharidosis II Price (USD/Pcs) by Type (2018-2034)
Figure 62. Global Sales Market Share of Mucopolysaccharidosis II by Application (2018-2034)
Figure 63. Global Revenue Market Share of Mucopolysaccharidosis II by Application (2018-2034)
Figure 64. Global Mucopolysaccharidosis II Price (USD/Pcs) by Application (2018-2034)
Figure 65. Mucopolysaccharidosis II Value Chain
Figure 66. Mucopolysaccharidosis II Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed